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Abstract
Background and Aim: While major efforts were made studying the complex etiology of
inflammatory bowel disease (IBD) including environmental factors, less is known about
underlying causes leading to the heterogeneous and highly variable course of disease. As
cigarette smoking cessation is the best‐known environmental factor with beneficial effect
in Crohn’s disease (CD), more exposome factors are likely involved. Further insights into
the role of the exposome in heterogeneity of disease might not only further knowledge of
underlying pathways, but also allow for better risk stratification.
Methods: Seven hundred twenty‐eight IBD patients completed the validated Groningen
IBD Environmental Questionnaire, collecting exposome data for 93 exposome factors. As-
sociations with disease course, that is, for need for surgery or biological therapy, were eval-
uated using univariate and multivariate‐adjusted logistic regression modeling.
Results: No significant associations were seen after Bonferroni correction. However, 11
novel exposome factors were identified with P < 0.05. Two factors were associated with
course of CD and ulcerative colitis (UC): beer (CD OR0.3/UC OR0.3) and cannabis
(0.5/2.2). While in CD, carpet flooring (0.5) was associated with biological use, and four
factors were associated with surgery: working shifts (1.8), appendectomy (2.4), frequent
tooth brushing (2.8), and large household size (0.1). For UC, migrants more often required
biologicals (10.2). Childhood underweight (3.4), amphetamine use (6.2), and cocaine use
(4.8) were associated with surgery. Five factors were replicated.
Conclusions: We identified 16 environmental factors nominally associated with biological
use and surgery in established IBD. These new insights form an important stepping stone to
guide research on biological pathways involved, risk stratification, tailor‐made interven-
tions, and preventive strategies in IBD.
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Introduction
Inflammatory bowel disease (IBD) consists of Crohn’s disease
(CD) and ulcerative colitis (UC), both chronic and relapsing in-
flammatory diseases of the gastrointestinal tract.1 While major ef-
forts have been made studying the complex etiology of IBD with a
role for the genome, microbiome, and exposome, as a measure of
environmental exposures during one’s lifetime, less is known
about the underlying causes leading to the heterogeneous and
highly variable course of disease.2,3 Whereas mild
immunomodulating therapy is effective in some patients, others
progress to a more severe disease that requires biological therapy.
Even, up to 80% of CD patients eventually need a surgical resec-
tion of affected bowel segments.1 The increased intensity of treat-
ment has led to a global decrease of IBD‐related surgery and
mortality. Yet along with the known importance of the exposome
in disease etiology, this has generated significant interest into the
potential effects of the exposome in disease course, its underlying
biological pathways and eventually the possibility to modify the
exposome to influence disease course.4
As in disease etiology, smoking is probably the best known
exposome factor involved in disease course, with a divergent ef-
fect for CD and UC.5 Among few available studies, a previous trial
showed the potential of personalized lifestyle interventions, with a
decrease of flares in CD patients aided to quit smoking.6 Likewise,
increased physical activity, not only associated with an improved
quality of life but also a decreased risk of active disease.7
However, as with disease etiology, it is likely that many more
yet to be identified exposome factors are involved in disease
course. Despite its potential desirable effects in management of
IBD, modifiable exposome factors have not been systematically
studied in the past.4 Therefore, their potential application remains
unknown.
In the current study, we aim to identify (modifiable) exposome
factors involved in course of IBD, possibly leading to a better un-
derstanding of underlying mechanisms, risk stratification, and po-
tential targets for implementation of personalized lifestyle
interventions in IBD. The effect of a wide range of exposome fac-
tors was examined using a validated questionnaire in a large cohort
of IBD patients.8,9
Materials and methods
Study population. We performed a case‐only cross‐sectional
study embedded within the longitudinal 1000IBD cohort of the
University Medical Center Groningen, a tertiary referral center in
the Netherlands.9 Patients enrolled in the 1000IBD cohort are pro-
spectively followed while detailed information is collected
concerning clinical characteristics as well as in‐depth
subphenotypes and molecular data, as described in detail
elsewhere.9 An overview of the process of inclusion of patients
in this study is shown in Figure 1.8
Data collection
Exposome data. The web‐based Groningen IBD Environmen-
tal Questionnaire (GIEQ) was used to obtain environmental data
from all patients.8 This questionnaire was previously validated
by our group, and detailed information concerning the develop-
ment of the GIEQ and its validation is published elsewhere.8 Next,
patients of the 1000IBD cohort were asked to enroll in the current
study from 2016 to 2017, after which the data collection was
finalized in March 2018. During this period, 728 patients com-
pleted the GIEQ. For patients without access to a computer, a
Figure 1 Overview of study inclusion strategies and participation. GIEQ, Groningen IBD Environmental Questionnaire; IBD, inflammatory bowel dis-
ease. [Color figure can be viewed at wileyonlinelibrary.com]
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paper version of the GIEQ was made available (n: 82, 11.3%). Out
of the 844 items within the GIEQ, 337 (39.7%) items, compris-
ing of 93 different exposome factors during childhood, the
present situation or independent of timing of disease develop-
ment was suitable to examination of their potential role in
course of IBD.
Clinical data. As part of the 1000IBD cohort, enrolled patients
are prospectively followed by their treating IBD specialist at the
outpatient IBD clinic of the University Medical Center Groningen
where extensive information on disease diagnosis as well as dis-
ease course is collected. The primary outcome measures were de-
termined to be the ever need for IBD‐related surgery (consisting of
abscess drainage, intestinal resection due to therapy resistance, fis-
tula or stricture formation or developed malignant disease, and
strictureplasty) and the ever need for biological therapy (consisting
of infliximab, adalimumab, golimumab, ustekinumab, and
vedolizumab).
Data analysis. First, to rule out potential selection‐bias, base-
line characteristics between participating and nonparticipating pa-
tients were compared using univariate statistical testing (Table S1).
For categorical variables, χ²‐square tests were used. Continuous
variables were compared between groups using either Mann–
Whitney U tests or one‐way ANOVA tests, based on variable distri-
bution. To examine the role of personality, the data reduction
method “principal component analysis” was run on the 64
personality‐related questions, forming two personality traits to be
studied in more detail: “neuroticism” and “conscientiousness.”
Based on the median, patients were stratified into a low or high
score of each trait. With these components, 65.1% of total data
variability was described, while all model assumptions were met
(Table S2).10
Next, all environmental factors were evaluated for their associa-
tion with either surgery or biological therapy using aforemen-
tioned univariate testing. In total, 52 factors reached a borderline
P value of < 0.10 in univariate testing and were selected for mul-
tivariate testing (Fig. 2). Binary logistic regression (LR) modeling
was used to estimate the odds ratio (OR) and 95% confidence
Figure 2 Heat map of nominally significant
exposome factors. [Color figure can be viewed at
wileyonlinelibrary.com]
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interval (95%CI) for each independent exposure, while adjusting
for the possible confounding effects of gender, age (in years), dis-
ease duration (in years), and smoking status (never/former/cur-
rent), using the “Enter” method. A P value of < 0.05 was
considered nominally significant. The Bonferroni method, based
on the multivariate testing of 52 factors, was used to determine a
statistical significance threshold, correcting for multiple testing,
of a P value < 9.62 × 104. Statistical analyses were performed
using SPSS statistical software Version 23 (SPSS Inc., Chicago, Il-
linois, USA).
Ethical consideration. The protocol of described study is in
line with the ethical guidelines of the 1975 Declaration of Helsinki
as reflected in approval by the medical ethical review board of the
University Medical Center Groningen, the Netherlands (approval
no.: 2017.138, date of approval 19‐9‐2017) for whom a returned
questionnaire was considered as an informed consent.
Results
In total, 1682 patients were invited to participate, of whom 728
completed the GIEQ (completion rate 40.1%, Fig. 1). Compared
with nonparticipating patients, participants were more often fe-
male and of Western origin (Table S1). Also, participants were
shown to need IBD‐related surgery more often than
non‐participants (36.0% vs 29.7%). Baseline characteristics of all
participants are shown in Table 1. Overall, 261 (35.9%) patients
required surgery while 256 (35.4%) patients required biological
therapy during their disease course, with the highest rate of need
for surgery (N:187, 54.0%) or biological therapy (N:184, 52.7%)
seen in CD patients. Ninety‐three exposome factors were exam-
ined in relation to biological use or surgery in CD as well as
UC. All nominal significant factors are shown in Figure 3 and
discussed below. Nonassociated factors with P values > 0.05 are
Table 1 Baseline characteristics of IBD patients
IBD† CD UC
Characteristic N: 728 N: 349 N: 347
Age Median (IQR) 50 (37–61) 48 (36–60) 51 (38–62)
Gender, female n (%) 443 (60.9) 238 (68.2) 188 (54.2)
Disease duration Median (IQR) 14 (8–21) 14 (8–22) 13 (8–21)
History of smoking
Never smoked n (%) 364 (50.0) 151 (43.3) 204 (58.8)
Former smoker n (%) 261 (35.9) 121 (34.7) 118 (34.0)
Active smoker n (%) 103 (14.1) 77 (22.1) 25 (7.2)
Need for surgery n (%) 261 (35.9) 187 (54.0) 61 (17.7)
Need for biologicals n (%) 256 (35.4) 184 (52.7) 75 (21.6)
CD, Crohn’s disease; IBD, inflammatory bowel disease; IQR, interquar-
tile range; n, number; UC, ulcerative colitis.
†Describing the full patient cohort, including 32 patients with IBD‐
unclassified.
Figure 3 Overview of all exposome factors associated with need for biologicals or surgery in Crohn’s disease and ulcerative colitis. *All P values
< 0.05. [Color figure can be viewed at wileyonlinelibrary.com]
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shown in Table S3. After Bonferroni correction for multiple test-
ing, none of the associated exposome factors remained statistically
significant for their association with course of IBD (Fig. 2).
Childhood exposures. In total, 21 childhood‐related expo-
sures were examined. While no associations were seen with course
of CD, several exposures showed a nominally significant associa-
tion to biological use or surgery in UC (Table 2). Patients of
non‐Western origin were more often used biological therapy (OR
10.2; 95%CI 1.7–60.4). UC patients describing their childhood
living area as urban were also more likely to need surgery than
those living in rural regions (OR 2.3; 95%CI 1.1–4.5). Finally, be-
ing underweight during childhood was more often seen in patients
that underwent surgery (OR 3.4; 95%CI 1.6–7.0).
Adult exposures. Next, 48 adulthood‐related factors were
examined (Table 3). In CD and UC, 13 and 7 factors, respectively,
showed a nominally significant association with biological use or
surgical intervention. In CD, current unemployment was more of-
ten seen in patients that underwent surgery (OR 1.9; 95%CI 1.2–
3.1) or biological therapy (OR 1.8; 95%CI 1.1–2.9), while no as-
sociations were seen for UC (P values ≥ 0.19). CD patients, who
were used to work in shifts however, had an approximately three-
fold increased risk of surgery (OR 2.9; 95%CI 1.0–8.1). Different
factors concerning current lifestyle were also associated with
course of disease. In CD, current cigarette smoking was more of-
ten seen in patients requiring biological therapy (OR 1.8; 95%CI
1.0–3.2) while regular passive smoke exposure increased risk of
surgery (OR 2.4; 95% CI 1.1–5.1). The use of cannabis showed
a divergent effect, with a reduced in risk of surgery in CD (OR
0.5; 95%CI 0.2–0.8), compared with an approximately twofold in-
creased risk of surgery in UC (OR 2.2; 95%CI 1.0–4.6). The use
of amphetamines (OR 6.2; 95%CI 1.6–23.9) as well as cocaine
(OR 4.8; 95%CI 1.1–20.0) showed a similar effect in UC but
not CD. Although the average amount of alcohol use per day
was not associated with biological use or surgery neither for CD
nor UC (all P values > 0.30, Table S3), patients choosing beer
as preferred alcoholic beverage less often needed biological ther-
apy in CD (OR 0.5; 95%CI 0.2–1.0) and UC (OR 0.3; 95%CI
0.1–0.7). CD patients who had a high physical activity score, how-
ever, less often needed biologicals (OR 0.4; 95%CI 0.2–0.8) while
abiding to the advised daily activity norm (exercising at least
30 min, 5 days per week) showed no association.11 Finally, a per-
ceived poor sleep quality was reported by 19.6% of patients with
IBD, especially more often in UC patients that underwent surgical
intervention (OR 2.8; 95%CI 1.4–5.9) while no associations were
observed for duration of sleep or the use of sleep‐related medica-
tions (all P values > 0.05).
Lifelong exposures. After examining 24 factors unrelated to
life stage, no association was seen in UC (Table 4). Different
hygiene‐related factors were associated with course of CD. While
patients brushing their teeth greater than twice per day showed an
increased risk of surgery (OR 2.8; 95%CI 1.1–7.3), no effect was
seen for the use of mouthwash. Additional adjusting of the LR
model for the potential confounding effect of dental state did not
alter these findings. A large household size showed an
approximately 10‐fold reduction in risk for surgical intervention
in CD (OR 0.1; 95%CI 0.0–0.6), as the presence of room‐wide
carpet did for the need for biologicals (OR 0.5; 95%CI 0.3–0.8).
A previous appendectomy was seen more often in CD patients
underwent IBD‐related surgery (OR 2.4; 95%CI 1.2–5.0).
Discussion
In this study, 93 exposures were systematically evaluated for their
role in the need for biological therapy and surgery in IBD. Al-
though no statistically significant associations were found, we
identified 11 potential novel nominal associations. We also repli-
cated five previously described factors, indicating robustness of
these associations. An overview of all nominal associations is
shown in Figure 3.
In contrast to disease etiology, childhood‐related exposures
seem to play less of a role in course of IBD.3 As differences in dis-
ease phenotypes have been previously described, this is the first
study describing more biological use in non‐Western migrants in
UC, but not CD, most likely due to differential inherent responses
to environmental triggers.12,13 Whereas childhood obesity was
previously related to several autoimmune diseases including CD,
this is the first study associating a poor nutritional status during
childhood to a higher risk of surgery later in life in UC
patients.14,15
Current adulthood‐related factors seem to hold stronger associa-
tions with the use of biologicals and need for surgery. In line with
Spekhorst et al,16 we show a higher risk of complicated disease
course in CD in those who are unemployed. Among CD patients
currently employed, working shifts was associated with a threefold
increased risk of surgical intervention. As working shifts inevita-
bly leads to sleep disruption, a role in not only etiology of IBD
but also its course seems plausible.17,18 The same line of reasoning
holds for the shown increased prevalence of poor sleep quality in
those requiring surgery, as sleep impairment was previously asso-
ciated with subclinical inflammation, alterations of gut microbiota,
and disease activity.19–21 The risk‐increasing effect of active as
well as passive cigarette smoking shown in CD is in line with pre-
vious studies.5,6,22 We found smaller effect sizes than previously
reported, which might be due to the decreased number of active
smokers in our cohort compared with previous cohorts, following
the global decrease of smoking in IBD patients.23 To our knowl-
edge, this is the first study describing the opposite effect of canna-
bis in UC and CD. IBD patients were previously shown to be more
likely to ever use cannabis than controls. Another small Israeli
study showed an improved quality of life and decreased surgery
rate.24–26 We also found and decreased risk for surgery in CD,
but an increasing risk in UC. Similar associations are shown for
amphetamine and cocaine use. Further research is needed to repli-
cate our findings and study these associations in more detail. The
role of alcohol consumption in course of IBD has been scarcely
studied in the past.27 Whereas previous studies have shown a po-
tential increase of symptoms in UC alone, this is the first study ex-
amining its role in biological use, showing no association for total
alcohol consumption, while beer consumption was seen more of-
ten in patients with no history of biological treatment.28,29 In line
with previous studies, this study shows a beneficial effect for phys-
ical activity in CD as well as UC.7,30 As a single work‐out was
KWJ van der Sloot et al. Exposome in IBD
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shown to inhibit monocyte tumor necrosis factor secretion in
healthy individuals, these findings seem biologically plausible.31
Regardless of life‐stage, the role of appendectomy has been
widely studied in disease etiology as well as course of disease. Al-
though an increased prevalence of stricturing CD has been associ-
ated with history of appendectomy, this is the first study showing
an increased surgery rate while disease behavior is unaffected
(data not shown).32 For UC, no associations were seen, in line with
a previous meta‐analysis.33 Surprisingly, several proxies of current
hygiene were also associated with biological use or surgery in the
current study. CD patients living in a large household were less
likely to require surgery. A similar effect was shown for the pres-
ence room‐wide carpet. Personality, evaluated using principal
component analysis, identified no associations to course of disease
for the two distinct personality traits neuroticism and conscien-
tiousness. While an independent role of personality in the
exposome can be argued, it is likely of influence on other impor-
tant exposome factors such as stress. In future studies, it would
be of great interest to evaluate interactions between personality
and other exposome factors involved. Finally, this study is the first
to describe a potential association between frequency of tooth
brushing and the need for surgery in CD. Whereas this finding
could just be another proxy in the previously suggested hygiene
hypothesis, there is also the microparticle theory. In this theory,
microparticles such as titanium dioxide and aluminum silicate, as
present in toothpaste, are hypothesized to play a role in CD by
forming strong stimulators of T‐lymphocytes and microphages in
experimental models.34,35 However, this theory remains controver-
sial, and further studies investigating the exact effect of micropar-
ticles in IBD are needed.
We acknowledge several limitations to the current study. First,
questionnaire‐based studies are at risk of recall bias. Although re-
call bias can never be prevented completely, the smart design of
the validated web‐based GIEQ limits its effects as described
elsewhere.8 Following the example of studies in the field of genet-
ics, starting at single‐gene studies and progressing to genome‐wide
association studies, using structured statistical approach while
correcting for multiple testing, similar steps are crucial to further
our knowledge on the exposome in IBD. The current study, how-
ever, has shown that for using this approach, larger cohorts are cru-
cial. A power calculation indicated an 80% power to detect ORs
below 1.45 within the current cohort. To allow for identification
of exposures with moderate effect sizes while correcting for multi-
ple testing in future studies, approximately 1300 patients per dis-
ease subtype are needed.
Also, an increase of participants and this power would allow for
studying more precise disease outcomes, that is subphenotypes of
disease, hospitalizations, and flares. Lastly, the current
cross‐sectional method is not suitable to study causality. As
knowledge of the exposome in course of IBD is limited, it merely
forms a stepping stone providing potential novel targets for future
prospective studies. A key strength of this study is formed by the
wide scope of exposome factors examined in this study, the largest
to date, while using a previously validated questionnaire. Also,
participants are all enrolled in the 1000IBD cohort ensuring cor-
rect and up to date information on disease course, preventing mis-
classification of diagnosis and complication development.
In this study, we present an overview of novel as well as repli-
cated exposome factors potentially associated with the need for
biologicals and surgery in IBD. Future prospective studies in large
cohorts are crucial to confirm these findings, further clarifying the
role of the exposome in disease course, as the exposome could po-
tentially be used to stratify those at risk of complicated disease and
guide both research on biological pathways involved, tailor‐made
intervention and preventive strategies in IBD.
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